Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire

Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire

  Introduction: Dysgeusia may occur during conventional or target-therapies and affect patients adherence-to-treatment. Therefore, it should be monitored to improve clinical outcome. To date, available questionnaires on dysgeusia relate to traditional antineoplastics and do not apply to target-ther...

Full description

Bibliographic Details
Main Authors: Elisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, Claudia Costa, Gabriella Fabbrocini, Matteo Megna, Luca Potestio, Angelo Ruggiero, Massimiliano Scalvenzi
Format: Article
Language:English
Published: Mattioli1885 2023-07-01
Series:Dermatology Practical & Conceptual
Subjects:
patient-reported outcome measure
dysgeusia
sonic hedgehog inhibitors
PROM
basal cell carcinoma
Online Access:http://dpcj.org/index.php/dpc/article/view/2887

Internet

http://dpcj.org/index.php/dpc/article/view/2887

Similar Items